Claritas Pharmaceuticals, Inc. Stock
Stocks
CLAZF
CA1806342061
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
11:09:11 2026-10-08 am EDT
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -.--% |
|
-.--% | - |
| Market Cap | 5.37M 3.84M 3.43M 3.15M 2.86M 363M 5.5M 37.57M 15.11M 192M 14.4M 14.09M 608M | P/E 2019 |
-0.74x | P/E 2020 | 0.13x |
|---|---|---|---|---|---|
| Enterprise Value | 6.29M 4.49M 4.01M 3.69M 3.35M 426M 6.45M 44.01M 17.7M 225M 16.86M 16.5M 712M | EV / Sales 2019 |
-
| EV / Sales 2020 | - |
| Free-Float |
99.74% | Yield 2019 * |
-
| Yield 2020 | - |
| 1 month | 0 |  | 0 |
| Current year | 0 | | 0 |
| 1 year | 0 | | 0 |
| 3 years | 0 | | 0 |
| 5 years | 0 | | 0.3 |
| 10 years | 0 | | 15.31 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Farrell
CEO | Chief Executive Officer | 76 | 2017-06-20 |
Victoria Rudman
DFI | Director of Finance/CFO | 58 | 2018-06-28 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Farrell
CHM | Chairman | 76 | 2021-03-17 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/11/21 | Buy | 118,000 | 0.3332% | |||
| 10/11/21 | Buy | 152,500 | 0.4307% | |||
| 10/11/21 | Buy | 24,500 | 0.0692% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 37 | |
| -2.43% | -4.38% | +40.32% | +55.64% | 60.57B | |
| +0.62% | +2.58% | +20.96% | +98.18% | 55.51B | |
| +0.61% | +0.77% | +11.13% | +69.42% | 55.22B | |
| +1.61% | -3.30% | +22.77% | +33.16% | 43.27B | |
| -1.74% | -3.02% | +13.83% | +93.17% | 40.36B | |
| +3.22% | +4.30% | +227.37% | +776.49% | 41.63B | |
| +0.57% | +24.09% | +99.46% | +84.11% | 33.29B | |
| -1.09% | +0.69% | +14.20% | +45.26% | 32.27B | |
| -4.46% | +9.98% | -43.92% | +320.28% | 22.91B | |
| Average | -0.31% | +3.05% | +45.13% | +175.08% | 38.5B | |
| Weighted average by Cap. | -0.17% | +2.15% | +46.73% | +160.43% |
| 2019 | 2020 | |
|---|---|---|
| Net sales | - | - |
| Net income | -21.21M -15.16M -13.54M -12.44M -11.3M -1.44B -21.75M -148M -59.72M -758M -56.89M -55.67M -2.4B | 4.21M 3.01M 2.69M 2.47M 2.24M 285M 4.32M 29.47M 11.85M 150M 11.29M 11.05M 477M |
| Net Debt | 704K 503K 449K 413K 375K 47.65M 722K 4.93M 1.98M 25.15M 1.89M 1.85M 79.71M | 920K 657K 587K 539K 490K 62.27M 943K 6.44M 2.59M 32.86M 2.47M 2.41M 104M |
Employees
-
- Stock Market
- Stocks
- CLAZF Stock
Select your edition
All financial news and data tailored to specific country editions
